Pseudoerythromycin A enol ether
(Synonyms: 伪赤藓霉素A烯醇醚,LY267108) 目录号 : GC40851
An erythromycin impurity used as an analytical standard
Cas No.:105882-69-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Pseudoerythromycin A enol ether is a degradation product of erythromycin. It does not possess antibiotic activity and can be used as an analytical standard for erythromycin A stability studies.
| Cas No. | 105882-69-7 | SDF | |
| 别名 | 伪赤藓霉素A烯醇醚,LY267108 | ||
| Canonical SMILES | O=C1OC([C@@]([C@H](O)CC)(O)C)[C@@H](C)C2=C(C)C[C@@](C)(O2)[C@H](O[C@]3([H])O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@@H](C)[C@H](O[C@@]4([H])C[C@](OC)(C)[C@@H](O)[C@H](C)O4)[C@H]1C | ||
| 分子式 | C37H65NO12 | 分子量 | 715.9 |
| 溶解度 | DMF: Soluble,DMSO: Soluble,Ethanol: Soluble,Methanol: Soluble | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.3968 mL | 6.9842 mL | 13.9684 mL |
| 5 mM | 0.2794 mL | 1.3968 mL | 2.7937 mL |
| 10 mM | 0.1397 mL | 0.6984 mL | 1.3968 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
A kinetic study on the degradation of erythromycin A in aqueous solution
Int J Pharm 2004 Mar 1;271(1-2):63-76.PMID:15129974DOI:10.1016/j.ijpharm.2003.10.023.
The pH is a critical factor determining the rate of the degradation of erythromycin A in aqueous solutions. However, the kinetics of the acid- and base-catalyzed degradation is still uncertain. This study used a sensitive coulometric detection method to determine concentrations of erythromycin A and its degradation products. To determine the buffer-independent rate constants, sodium acetate (0.05-0.2 M) and Tris-HCl (0.1-0.5 M) were used in a pH range of 3.5-5.5 and 7.0-9.0, respectively. In acidic conditions, anhydroerythromycin A appeared to be produced directly through an internal dehydration of erythromycin A-6,9-hemiketal which simultaneously established an equilibrium with erythromycin A enol ether on the other hand. In weakly alkaline conditions, hydroxide ion appeared to catalyze the hydrolysis of the lactonyl ester bond of erythromycin A-6,9-hemiketal by the pseudo-first-order kinetics, and the C13 --> C11 translactonization and internal dehydration reactions subsequently occurred to form Pseudoerythromycin A enol ether. We suggest here a predictive model for reasonable interpretation of the kinetics of erythromycin A degradation in aqueous solutions, in which the observed rate constant was expressed by the sum of the partial reaction rate constants for the acid- and base-catalyzed degradation of erythromycin A-6,9-hemiketal as a function of pH in a range of 3.0-10.0.
Study of the stability of erythromycin in a hydrophilic creme basis by liquid chromatography
J Pharm Biomed Anal 1998 May;17(1):53-6.PMID:9608426DOI:10.1016/s0731-7085(97)00158-1.
The stability of the macrolide antibiotic erythromycin, incorporated at a 2% m/m concentration in a hydrophilic creme basis containing 2% m/m of chlorocresol, was monitored over a period of 2 months using liquid chromatography as the analytical method. Extracts of the creme were analysed using wide-pore poly(styrene-divinylbenzene) PLRP-S 1000 A as the stationary phase and a mixture of 2-methyl-2-propanol-acetonitrile-potassium phosphate buffer (pH 11.0; 0.02 M)-water (165:30:50:755, v/v/v/v) as the mobile phase. The method showed good selectivity towards chlorocresol, erythromycin A, its related substances and degradation products. As the pH of the creme containing erythromycin was 8.6, alkaline degradation products were expected to be formed. The presence of Pseudoerythromycin A enol ether was observed after storage of the creme for 1 week at a temperature of 25 degrees C. After 1 month the content of erythromycin was still more than 95%.
Voltammetric investigation of macrolides by an HPLC-coulometric assay
J Pharm Biomed Anal 2005 Jul 1;38(3):390-6.PMID:15925238DOI:10.1016/j.jpba.2005.01.028.
Voltammograms of macrolides, including anhydroerythromycin A, azithromycin, erythromycin A, erythromycin A enol ether, Pseudoerythromycin A enol ether, oleandomycin and tylosin have been investigated using a dual electrode cell in combination with a high-throughput LC method. The half-wave potentials (E(1/2)) of the seven macrolides investigated ranged from 0.734 to 0.866 V, and the current responses reached the maxima at over 1.0 V. The current response of the downstream electrode displayed a non-linear behavior at high potentials over +0.75 V, probably because of polarization of solvent components, e.g., water. The HPLC-coulometric assay was optimized with the potentials of the upstream and downstream electrodes at +0.65 and +0.85 V, respectively. This method is suitable for detection of 14- and 15-membered macrolides (sensitivity<0.05 microg ml(-1)), but not for a 16-membered macrolide, tylosin (sensitivity>0.1 microg ml(-1)). The assay shows interferences from biomatrices in rat's blood plasma and serum, and human urine, but they were effectively removed by a cold acetonitrile extraction method.